These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37752527)

  • 41. Recent changes in trends of opioid overdose deaths in North America.
    Imtiaz S; Shield KD; Fischer B; Elton-Marshall T; Sornpaisarn B; Probst C; Rehm J
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):66. PubMed ID: 32867799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Virtual overdose monitoring services and overdose prevention technologies: Opportunities, limitations, and future directions.
    Rioux W; Marshall T; Ghosh SM
    Int J Drug Policy; 2023 Sep; 119():104121. PubMed ID: 37453373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.
    Gomes T; Khuu W; Craiovan D; Martins D; Hunt J; Lee K; Tadrous M; Mamdani MM; Paterson JM; Juurlink DN
    Drug Alcohol Depend; 2018 Oct; 191():86-90. PubMed ID: 30096638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urban overdose hotspots: a 12-month prospective study in Dublin ambulance services.
    Klimas J; O'Reilly M; Egan M; Tobin H; Bury G
    Am J Emerg Med; 2014 Oct; 32(10):1168-73. PubMed ID: 25154346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of community healthcare and overdose in the 30 days following release from provincial correctional facilities in British Columbia.
    McLeod KE; Karim ME; Buxton JA; Martin RE; Scow M; Felicella G; Slaunwhite AK
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109113. PubMed ID: 34823082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.
    Behrends CN; Paone D; Nolan ML; Tuazon E; Murphy SM; Kapadia SN; Jeng PJ; Bayoumi AM; Kunins HV; Schackman BR
    J Subst Abuse Treat; 2019 Nov; 106():79-88. PubMed ID: 31540615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada.
    Mayer S; Boyd J; Collins A; Kennedy MC; Fairbairn N; McNeil R
    Drug Alcohol Depend; 2018 Dec; 193():69-74. PubMed ID: 30343236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unintentional opioid overdose deaths in New York City, 2005-2010: a place-based approach to reduce risk.
    Siegler A; Tuazon E; Bradley O'Brien D; Paone D
    Int J Drug Policy; 2014 May; 25(3):569-74. PubMed ID: 24412006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study.
    Moustaqim-Barrette A; Papamihali K; Williams S; Ferguson M; Moe J; Purssell R; Buxton JA
    PLoS One; 2021; 16(10):e0259126. PubMed ID: 34714854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada.
    Moshkforoush M; DeBeck K; Brar R; Fairbairn N; Cui Z; Milloy MJ; Buxton J; Oldenburger T; McLellan W; Kendall P; Sedgemore K; Wilson D; Kerr T; Hayashi K
    Harm Reduct J; 2022 May; 19(1):50. PubMed ID: 35614440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patterns of health care utilization among people who overdosed from illegal drugs: a descriptive analysis using the BC Provincial Overdose Cohort.
    Otterstatter MC; Crabtree A; Dobrer S; Kinniburgh B; Klar S; Leamon A; May-Hadford J; Mill C; Park M; Tu AW; Zheng L
    Health Promot Chronic Dis Prev Can; 2018 Sep; 38(9):328-333. PubMed ID: 30226726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Low-Barrier and Comprehensive Community-Based Harm-Reduction Site in Vancouver, Canada.
    Olding M; Ivsins A; Mayer S; Betsos A; Boyd J; Sutherland C; Culbertson C; Kerr T; McNeil R
    Am J Public Health; 2020 Jun; 110(6):833-835. PubMed ID: 32298171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users.
    Frank D; Mateu-Gelabert P; Guarino H; Bennett A; Wendel T; Jessell L; Teper A
    Int J Drug Policy; 2015 Jan; 26(1):84-91. PubMed ID: 25151334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).
    Moreheart S; Shannon K; Krüsi A; McDermid J; Ettinger E; Braschel M; Goldenberg SM
    Int J Drug Policy; 2023 Nov; 121():104212. PubMed ID: 37797570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study.
    Ferguson M; Choisil P; Lamb J; Burmeister C; Newman C; Lock K; Tobias S; Liu L; Buxton JA
    Harm Reduct J; 2023 Dec; 20(1):178. PubMed ID: 38093272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rigidity, dyskinesia and other atypical overdose presentations observed at a supervised injection site, Vancouver, Canada.
    Kinshella MW; Gauthier T; Lysyshyn M
    Harm Reduct J; 2018 Dec; 15(1):64. PubMed ID: 30577844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prescription-, Illicit-, and Self-Harm Opioid Overdose Cases Treated in Hospital.
    Conner KR; Wiegand TJ; Kaukeinen K; Gorodetsky R; Schult R; Heavey SC
    J Stud Alcohol Drugs; 2018 Nov; 79(6):893-898. PubMed ID: 30573020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
    Pizzicato LN; Johnson CC; Viner KM
    Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
    [No Abstract]   [Full Text] [Related]  

  • 60. Differential risks of syringe service program participants in Central Ohio: a latent class analysis.
    Moon KJ; Bryant I; Trinh A; Hasenstab KA; Carter B; Barclay R; Nawaz S
    Harm Reduct J; 2023 Jul; 20(1):97. PubMed ID: 37507721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.